This study aimed to investigate the pharmacokinetics of danofloxacin in red-eared slider turtle (
Trachemys scripta elegans
) following a single intravenous (IV) and
intramuscular (IM) administrations of 6 mg/kg, using a two-way crossover study with 30-day washout period. Eight clinically healthy red-eared slider turtle weighing 410–600 g (mean 490 g)
were used for the study. Danofloxacin concentrations were measured using the reversed-phase high-performance liquid chromatography. The plasma concentration-time data were evaluated by a
non-compartmental method. After IV administration, the elimination half-life (t
1/2ʎz
), mean residence time (MRT
0-∞
), area under the concentration-time curve
(AUC
0-∞
), volume of distribution at steady state and total body clearance in plasma were 24.17 hr, 30.64 hr, 143.31 hr·
µ
g/m
l
, 1.29
l
/kg and 0.04
l
/hr/kg, respectively. Following IM administration, t
1/2ʎz
, MRT
0-∞
, AUC
0-∞
, peak concentration
(C
max
), time to reach C
max
, and bioavailability in plasma were 32.00 hr, 41.15 hr, 198.23 hr·
µ
g/m
l
, 8.75
µ
g/m
l
, 1.5 hr and 139.89%, respectively. Danofloxacin has clinically superior pharmacokinetic properties, including the complete IM absorption, slow
elimination and wide volume of distribution in red-eared slider turtles. However, further pharmacokinetics/pharmacodynamics studies are necessary for the treatment of diseases caused by
susceptible bacteria with known minimum inhibitory concentration values in red-eared slider turtles.